32 / 41
Volume 6, Issue 4 (Suppl)
Clin Pharmacol Biopharm, an open access journal
ISSN: 2167-065X
Page 86
Euro Biopharma & Ethnopharmacology 2017
November 09-11, 2017
&
6
th
International Conference and Exhibition on
November 09-11, 2017 Vienna, Austria
4
th
EUROPEAN BIOPHARMA CONGRESS
PHARMACOLOGY AND ETHNOPHARMACOLOGY
Joint Event
Selenium and its compousends as perspektive drugs in onkology
Melnik Milan
Faculty of Medicine Comenius University in Bratislava, Slovakia
I
n last years, hhere have been some notable developments as several areas of inorganic pharmaceutical that have potentially
for – reacting importance for future medicial applications and reasearch. One of the highly significant developmeats in
the field of oncology and hematology is the application role selenium compounds. Selenium ions play an important role in
biological systems, and without their catalytic presence interrace or ultratrace amouts many essential co – factors for many
biochemical reactions would endogenous antioxidant enzymes. Selenium is an essential component of several endogenous
antioxidant enzymes. Selenium affects the transugtion of multiple defense and regair genes to protect against metal – induced
pathologies. Selenium creates stable compleces a wide variety of organic molecules that canprovide required biological afinity
and therapeutical activity veritable for tangeling specific locations in the body. The aim of this revier is a critical evalution of
selenium complexes used for therapy or diagnosis of various diseases in oncology.
Clin Pharmacol Biopharm 2017, 6:4(Suppl)
DOI: 10.4172/2167-065X-C1-026